Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,885,000 | 12,000,000 | 7,517,000 | 8,726,000 | 3,625,000 |
| Marketable Securities | 289,000 | 260,000 | 11,413,000 | 10,377,000 | 16,133,000 |
| Receivables | 9,543,000 | 9,183,000 | 8,334,000 | 8,680,000 | 8,910,000 |
| Inventories | 8,228,000 | 7,886,000 | 7,175,000 | 6,779,000 | 6,880,000 |
| Other current assets | 4,548,000 | 2,785,000 | 2,471,000 | 2,392,000 | 2,594,000 |
| TOTAL | $33,493,000 | $32,114,000 | $36,910,000 | $36,954,000 | $38,142,000 |
| Non-Current Assets | |||||
| PPE Net | 10,825,000 | 10,841,000 | 10,764,000 | 10,315,000 | 10,733,000 |
| Investments And Advances | 2,433,000 | 2,555,000 | 2,554,000 | 2,491,000 | 2,580,000 |
| Intangibles | 57,525,000 | 59,932,000 | 60,945,000 | 60,556,000 | 62,480,000 |
| Other Non-Current Assets | 6,703,000 | 6,799,000 | 6,280,000 | 8,148,000 | 8,975,000 |
| TOTAL | $77,486,000 | $80,127,000 | $80,543,000 | $81,510,000 | $84,768,000 |
| Total Assets | $110,979,000 | $112,241,000 | $117,453,000 | $118,464,000 | $122,910,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,289,000 | 6,968,000 | 5,931,000 | 7,055,000 | 7,045,000 |
| Accounts payable and accrued liabilities | 5,350,000 | 5,426,000 | 5,146,000 | 4,693,000 | 4,969,000 |
| Other current liabilities | 15,372,000 | 14,938,000 | 14,795,000 | 13,475,000 | 12,929,000 |
| TOTAL | $31,909,000 | $30,549,000 | $28,656,000 | $28,160,000 | $27,646,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,259,000 | 20,396,000 | 20,244,000 | 19,732,000 | 22,232,000 |
| Other Non-Current Liabilities | 6,353,000 | 6,426,000 | 6,444,000 | 6,953,000 | 6,903,000 |
| TOTAL | $27,139,000 | $29,550,000 | $29,374,000 | $29,406,000 | $32,258,000 |
| Total Liabilities | $59,048,000 | $60,099,000 | $58,030,000 | $57,566,000 | $59,904,000 |
| Shareholders' Equity | |||||
| Common Shares | 842,000 | 842,000 | 890,000 | 890,000 | 890,000 |
| Retained earnings | 51,057,000 | 51,253,000 | 58,544,000 | 60,000,000 | 62,095,000 |
| Other shareholders' equity | 84,000 | 83,000 | 81,000 | 78,000 | 81,000 |
| TOTAL | $51,931,000 | $52,142,000 | $59,423,000 | $60,898,000 | $63,006,000 |
| Total Liabilities And Equity | $110,979,000 | $112,241,000 | $117,453,000 | $118,464,000 | $122,910,000 |